Clinical pathophysiology of the somatotropic (GH) axis in adults

A. Iranmanesh, J. D. Veldhuis

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


In summary, GH secretion and, to a lesser extent, GH metabolic clearance, are subject to regulation in health and disease. Nutritional, body compositional, metabolic, and age-related and sex-steroid related mechanisms as well as adrenal glucocorticoids, thyroid hormones, and renal and hepatic function all govern pulsatile GH release in adults. Moreover, tissue resistance to GH action may occur as an inborn (Laron dwarf) or acquired (fasting, diabetes mellitus, chronic renal failure) defect and modulate the function of the somatotropic axis. Finally, GH action is controlled by the local synthesis of IGFs and their binding proteins in target tissues.

Original languageEnglish (US)
Pages (from-to)783-816
Number of pages34
JournalEndocrinology and Metabolism Clinics of North America
Issue number4
StatePublished - 1992

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Clinical pathophysiology of the somatotropic (GH) axis in adults'. Together they form a unique fingerprint.

Cite this